Sistema de Bibliotecas Universidad de Santander

Current progress in medical mycology / Héctor M. Mora-Montes, Leila M. Lopes-Bezerra, editors.

Contributor(s): Mora-Montes, Hector Manuel [editor.] | Lopes-Bezerra, Leila M [editor.]Material type: TextTextLanguage: English Publisher: México Springer 2017Description: 425 p. illustrationsISBN: 9783319641133; 3319641131Subject(s): Medical mycology | Mycology | HEALTH & FITNESS -- Diseases -- General | MEDICAL -- Clinical Medicine | MEDICAL -- Diseases | MEDICAL -- Evidence-Based Medicine | MEDICAL -- Internal Medicine | Medical mycology | Mycology | MICOLOGÍA MÉDICA | MICOLOGÍAGenre/Form: Electronic books. DDC classification: 616.015 Online resources: Ebook Library | EBSCOhost | SpringerLink | SpringerLink | SpringerLink | SpringerLink | Check for Full Text Access restricted: SMU users only | Connect to Springer e-book | SpringerLink eBook available for UOIT via SpringerLink. Click link to access
Contents:
""Preface""; ""Contents""; ""Contributors""; ""Chapter 1: Introduction to Medical Mycology""; ""1.1 Definition and Structure""; ""1.2 Emergence of Challenge Due to Fungal Infections""; ""1.3 Spectrum of Fungal Infections""; ""1.3.1 Superficial Mycoses""; ""1.3.2 Invasive/Opportunistic Mycoses""; ""1.3.3 Endemic Mycoses""; ""1.3.4 Allergic Manifestations""; ""1.4 Classification""; ""1.5 Epidemiology of Fungal Infections""; ""1.5.1 Global Burden of Disease""; ""1.5.2 Predisposing Factors for Fungal Infections""; ""1.5.3 Geographical Distribution""
""1.5.4 Community Acquired Fungal Infections""""1.5.5 Nosocomial Fungal Infections""; ""1.6 Fungal Infection Immunity and Pathogenesis""; ""1.6.1 Innate Immunity""; ""1.6.2 Adaptive Immunity""; ""1.6.3 Fungal Virulence""; ""1.6.4 Tissue Reaction""; ""1.7 Diagnosis of Fungal Infections""; ""1.7.1 Radiological Imaging""; ""1.7.2 Conventional and Culture Based Diagnosis""; ""1.7.3 Sepsis Biomarkers""; ""1.7.4 Serology""; ""1.7.5 Molecular Detection""; ""1.8 Treatment""; ""1.9 Fungal Vaccines""; ""References""; ""Chapter 2: Antifungal Drugs""
""2.1 Polyenes (Amphotericin B Deoxycholate and Its Lipid-�Associated Formulations)""""2.1.1 Amphotericin B Deoxicholate""; ""2.1.1.1 Chemical Structure""; ""2.1.1.2 Mechanism of Action""; ""2.1.1.3 Pharmacokinetics and Pharmacodynamics""; ""2.1.1.4 Spectrum of Activities and Resistance""; ""2.1.1.5 Clinical Uses""; ""2.1.1.6 Dosing""; ""2.1.1.7 Adverse Events and Toxicity""; ""2.1.1.8 Contraindication""; ""2.1.1.9 Drug Interactions""; ""2.1.1.10 Use in Special Population""; ""2.1.2 Lipid Formulations of Amphotericin B""; ""2.1.2.1 Dosing""; ""2.1.2.2 Adverse Events and Toxicity""
""2.2 Triazole Antifungal Agents""""2.2.1 General Properties""; ""2.2.1.1 Chemical Structure""; ""2.2.1.2 Mechanism of Action""; ""2.2.1.3 Pharmacokinetics""; ""2.2.1.4 Spectrum of Activity and Resistance""; ""2.2.1.5 Clinical Utility""; ""2.2.1.6 Adverse Events and Drug Interactions""; ""2.2.1.7 Dosing and Administration. Use in Special Populations""; ""2.2.2 Individual Agents""; ""2.2.2.1 Itraconazole""; ""2.2.2.2 Fluconazole""; ""2.2.2.3 Voriconazole""; ""2.2.2.4 Posaconazole""; ""2.2.2.5 Isavuconazole""
""2.2.3 Newer and Investigational Agents: Efinaconazole, Albaconazole, Ravuconazole and Others""""2.3 Echinocandins""; ""2.3.1 Chemical Structure""; ""2.3.2 Mechanism of Action""; ""2.3.3 Pharmacokinetics and Pharmacodynamics""; ""2.3.4 Spectrum of Activity and Resistance""; ""2.3.5 Clinical Uses""; ""2.3.6 Adverse Events and Toxicity""; ""2.3.7 Drug Interactions""; ""2.3.8 Use in Special Population and Dose Adjustments""; ""2.3.9 Adult Dosing""; ""2.3.10 New Echinocandin""; ""2.4 Flucytosine""; ""2.4.1 Chemical Structure""; ""2.4.2 Mechanism of Action""
Summary: Infections caused by fungi have recently attracted the attention of both clinicians and basic researchers given the heavy burden they represent for any health system. The mortality and morbidity rates associated to mycosis are progressively rising simply because some of these diseases are still neglected by health-care workers and due to the changing sensitivity to antifungal drugs displayed by these organisms. In this book, both researchers and clinicians working in the medical mycology field explore the most recent literature about specific mycosis; placing in one concise chapter thoroughly revisions of the current knowledge on virulence factors, recognition by immune cells, immunoevasion, epidemiology, new diagnosis trends and therapeutics. This book is recommended to researchers, physicians and students interested in medical mycology.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Item type Current location Collection Call number Copy number Status Date due Barcode Item holds
Libros / General Libros / General Biblioteca Central UDES- Bucaramanga
Colección General 616.015 C877 (Browse shelf) Ej. 1 Available 028527
Total holds: 0

Includes bibliographical references.

""Preface""; ""Contents""; ""Contributors""; ""Chapter 1: Introduction to Medical Mycology""; ""1.1 Definition and Structure""; ""1.2 Emergence of Challenge Due to Fungal Infections""; ""1.3 Spectrum of Fungal Infections""; ""1.3.1 Superficial Mycoses""; ""1.3.2 Invasive/Opportunistic Mycoses""; ""1.3.3 Endemic Mycoses""; ""1.3.4 Allergic Manifestations""; ""1.4 Classification""; ""1.5 Epidemiology of Fungal Infections""; ""1.5.1 Global Burden of Disease""; ""1.5.2 Predisposing Factors for Fungal Infections""; ""1.5.3 Geographical Distribution""

""1.5.4 Community Acquired Fungal Infections""""1.5.5 Nosocomial Fungal Infections""; ""1.6 Fungal Infection Immunity and Pathogenesis""; ""1.6.1 Innate Immunity""; ""1.6.2 Adaptive Immunity""; ""1.6.3 Fungal Virulence""; ""1.6.4 Tissue Reaction""; ""1.7 Diagnosis of Fungal Infections""; ""1.7.1 Radiological Imaging""; ""1.7.2 Conventional and Culture Based Diagnosis""; ""1.7.3 Sepsis Biomarkers""; ""1.7.4 Serology""; ""1.7.5 Molecular Detection""; ""1.8 Treatment""; ""1.9 Fungal Vaccines""; ""References""; ""Chapter 2: Antifungal Drugs""

""2.1 Polyenes (Amphotericin B Deoxycholate and Its Lipid-�Associated Formulations)""""2.1.1 Amphotericin B Deoxicholate""; ""2.1.1.1 Chemical Structure""; ""2.1.1.2 Mechanism of Action""; ""2.1.1.3 Pharmacokinetics and Pharmacodynamics""; ""2.1.1.4 Spectrum of Activities and Resistance""; ""2.1.1.5 Clinical Uses""; ""2.1.1.6 Dosing""; ""2.1.1.7 Adverse Events and Toxicity""; ""2.1.1.8 Contraindication""; ""2.1.1.9 Drug Interactions""; ""2.1.1.10 Use in Special Population""; ""2.1.2 Lipid Formulations of Amphotericin B""; ""2.1.2.1 Dosing""; ""2.1.2.2 Adverse Events and Toxicity""

""2.2 Triazole Antifungal Agents""""2.2.1 General Properties""; ""2.2.1.1 Chemical Structure""; ""2.2.1.2 Mechanism of Action""; ""2.2.1.3 Pharmacokinetics""; ""2.2.1.4 Spectrum of Activity and Resistance""; ""2.2.1.5 Clinical Utility""; ""2.2.1.6 Adverse Events and Drug Interactions""; ""2.2.1.7 Dosing and Administration. Use in Special Populations""; ""2.2.2 Individual Agents""; ""2.2.2.1 Itraconazole""; ""2.2.2.2 Fluconazole""; ""2.2.2.3 Voriconazole""; ""2.2.2.4 Posaconazole""; ""2.2.2.5 Isavuconazole""

""2.2.3 Newer and Investigational Agents: Efinaconazole, Albaconazole, Ravuconazole and Others""""2.3 Echinocandins""; ""2.3.1 Chemical Structure""; ""2.3.2 Mechanism of Action""; ""2.3.3 Pharmacokinetics and Pharmacodynamics""; ""2.3.4 Spectrum of Activity and Resistance""; ""2.3.5 Clinical Uses""; ""2.3.6 Adverse Events and Toxicity""; ""2.3.7 Drug Interactions""; ""2.3.8 Use in Special Population and Dose Adjustments""; ""2.3.9 Adult Dosing""; ""2.3.10 New Echinocandin""; ""2.4 Flucytosine""; ""2.4.1 Chemical Structure""; ""2.4.2 Mechanism of Action""

Infections caused by fungi have recently attracted the attention of both clinicians and basic researchers given the heavy burden they represent for any health system. The mortality and morbidity rates associated to mycosis are progressively rising simply because some of these diseases are still neglected by health-care workers and due to the changing sensitivity to antifungal drugs displayed by these organisms. In this book, both researchers and clinicians working in the medical mycology field explore the most recent literature about specific mycosis; placing in one concise chapter thoroughly revisions of the current knowledge on virulence factors, recognition by immune cells, immunoevasion, epidemiology, new diagnosis trends and therapeutics. This book is recommended to researchers, physicians and students interested in medical mycology.

There are no comments on this title.

to post a comment.
Copyright © 2014 Universidad de Santander :: PBX 57-7-6516500 - Todos los derechos reservados
Institución sujeta a inspección y vigilancia por el MEN